Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 8,28 | 8,28 | 2024-03-26 |
| Valcuria Holding AB | 3,86 | 3,86 | 2024-03-26 |
| Ben Hayes | 2,32 | 2,32 | 2024-03-26 |
| Hans Harvig | 1,72 | 1,72 | 2024-03-26 |
| Hans Mandahl | 1,20 | 1,20 | 2024-03-26 |
| Benny Bengtsson | 1,09 | 1,09 | 2024-03-26 |
| Göran Lennart Rehn | 0,99 | 0,99 | 2024-03-26 |
| Hartmut Wiese | 0,99 | 0,99 | 2024-03-26 |
| Christian Müller | 0,99 | 0,99 | 2024-03-26 |
| Nordnet Pensionsförsäkring | 0,90 | 0,90 | 2024-03-26 |
2024-08-06 Delårsrapport 2024-Q2
2024-11-12 Delårsrapport 2024-Q3
2025-02-11 Bokslutskommuniké 2024
